基于区域化代谢特征和瘤信号通路的肝细胞癌的分子分类
Tomoko Aoki1, Naoshi Nishida1, Yutaka Kurebayashi2
1Department of Gastroenterology and Hepatology/Kindai University Faculty of Medicine, Osaka-Sayama, Japan.
Clinical and molecular hepatology
|March 11, 2025
概括
肝细胞癌 (HCC) 可以通过肝脏代谢和糖解来分类. 两个子类",丰富的新陈代谢"和"糖解",显示出不同的特征和预后,为HCC异质性提供了新的见解.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 代谢研究研究 代谢研究
背景情况:
- 之前的工作强调按生理功能分类肝细胞癌 (HCC).
- 这项研究侧重于肝脏内在代谢和癌细胞糖解,以对HCC进行分类.
研究的目的:
- 根据肝脏特异性新陈代谢和癌细胞糖解来分类HCC.
- 为了将这种新分类与现有的分子,遗传病学和血液动力学分类进行比较.
主要方法:
- 使用了全面的RNA/DNA测序,免疫组织化学和放射性评估.
- 在培训队列 (n=136) 上应用了HCC分类的等级分类,并对916个公共样本进行了验证.
主要成果:
- 确定了两个主要的HCC子类:"丰富的新陈代谢" (60.3%) 和"糖解" (39.7%).
- "丰富的新陈代谢"子类表现出增强的脂质代谢,更好的分化和有利的预后 (Hoshida S3).
- "糖溶解"子类表现出脱差,信号通路发生变化 (PI3K/mTOR,NOTCH/TGF-β) 和预后不佳 (霍希达S1/2).
结论:
- 肝脏特异性新陈代谢的丧失与形态脱差相关.
- 在HCC中细胞脱差可能具有双重的生理和病理作用.
- 肝脏成熟和区分路径对于定义HCC多样性至关重要.
相关概念视频
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Liver Regeneration
3.2K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
3.2K
Cancer-Critical Genes I: Proto-oncogenes
8.6K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.6K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K


